AFYA Quote, Financials, Valuation and Earnings

BRF SA has a net margin of 26.91% compared to Afya's net margin of 7.25%. Afya's return on equity of 16.16% beat BRF SA's return on equity of 22.56%.

Afya has a consensus price target of $19.98, signalling upside risk potential of 30.93%. On the other hand BRF SA has an analysts' consensus of $3.50 which suggests that it could fall by -5.15%. Given that Afya has higher upside potential than BRF SA, analysts believe Afya is more attractive than BRF SA.

Afya has a beta of 0.580, which suggesting that the stock is 41.967% less volatile than S&P 500. In comparison BRF SA has a beta of 1.330, suggesting its more volatile than the S&P 500 by 33.019%.

Afya has a quarterly dividend of $0.23 per share corresponding to a yield of 1.52%. BRF SA offers a yield of 3.17% to investors and pays a quarterly dividend of $0.02 per share. Afya pays -- of its earnings as a dividend. BRF SA pays out 35.62% of its earnings as a dividend. BRF SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Afya quarterly revenues are $159.7M, which are smaller than BRF SA quarterly revenues of $2.6B. Afya's net income of $43M is lower than BRF SA's net income of $191.8M. Notably, Afya's price-to-earnings ratio is 11.53x while BRF SA's PE ratio is 8.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.31x versus 0.54x for BRF SA. Usually stocks with elevated PS ratios are considered overvalued.

JBS NV has a net margin of 26.91% compared to Afya's net margin of 2.56%. Afya's return on equity of 16.16% beat JBS NV's return on equity of 24.14%.

Afya has a consensus price target of $19.98, signalling upside risk potential of 30.93%. On the other hand JBS NV has an analysts' consensus of -- which suggests that it could fall by --. Given that Afya has higher upside potential than JBS NV, analysts believe Afya is more attractive than JBS NV.

Afya has a beta of 0.580, which suggesting that the stock is 41.967% less volatile than S&P 500. In comparison JBS NV has a beta of 0.797, suggesting its less volatile than the S&P 500 by 20.317%.

Afya has a quarterly dividend of $0.23 per share corresponding to a yield of 1.52%. JBS NV offers a yield of 10.6% to investors and pays a quarterly dividend of $0.36 per share. Afya pays -- of its earnings as a dividend. JBS NV pays out 42.97% of its earnings as a dividend. JBS NV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Afya quarterly revenues are $159.7M, which are smaller than JBS NV quarterly revenues of $19.5B. Afya's net income of $43M is lower than JBS NV's net income of $498.7M. Notably, Afya's price-to-earnings ratio is 11.53x while JBS NV's PE ratio is 13.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.31x versus 0.34x for JBS NV. Usually stocks with elevated PS ratios are considered overvalued.

Brasilagro - Cia Bras de Prop Agricolas has a net margin of 26.91% compared to Afya's net margin of -0.64%. Afya's return on equity of 16.16% beat Brasilagro - Cia Bras de Prop Agricolas's return on equity of 15.16%.

Afya has a consensus price target of $19.98, signalling upside risk potential of 30.93%. On the other hand Brasilagro - Cia Bras de Prop Agricolas has an analysts' consensus of -- which suggests that it could fall by --. Given that Afya has higher upside potential than Brasilagro - Cia Bras de Prop Agricolas, analysts believe Afya is more attractive than Brasilagro - Cia Bras de Prop Agricolas.

Afya has a beta of 0.580, which suggesting that the stock is 41.967% less volatile than S&P 500. In comparison Brasilagro - Cia Bras de Prop Agricolas has a beta of 0.475, suggesting its less volatile than the S&P 500 by 52.494%.

Afya has a quarterly dividend of $0.23 per share corresponding to a yield of 1.52%. Brasilagro - Cia Bras de Prop Agricolas offers a yield of 7.07% to investors and pays a quarterly dividend of $0.27 per share. Afya pays -- of its earnings as a dividend. Brasilagro - Cia Bras de Prop Agricolas pays out 140.63% of its earnings as a dividend.

Afya quarterly revenues are $159.7M, which are larger than Brasilagro - Cia Bras de Prop Agricolas quarterly revenues of $29M. Afya's net income of $43M is higher than Brasilagro - Cia Bras de Prop Agricolas's net income of -$186.4K. Notably, Afya's price-to-earnings ratio is 11.53x while Brasilagro - Cia Bras de Prop Agricolas's PE ratio is 6.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.31x versus 1.70x for Brasilagro - Cia Bras de Prop Agricolas. Usually stocks with elevated PS ratios are considered overvalued.

Vasta Platform has a net margin of 26.91% compared to Afya's net margin of -0.76%. Afya's return on equity of 16.16% beat Vasta Platform's return on equity of 9.17%.

Afya has a consensus price target of $19.98, signalling upside risk potential of 30.93%. On the other hand Vasta Platform has an analysts' consensus of $3.27 which suggests that it could fall by -21.11%. Given that Afya has higher upside potential than Vasta Platform, analysts believe Afya is more attractive than Vasta Platform.

Afya has a beta of 0.580, which suggesting that the stock is 41.967% less volatile than S&P 500. In comparison Vasta Platform has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Afya has a quarterly dividend of $0.23 per share corresponding to a yield of 1.52%. Vasta Platform offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Afya pays -- of its earnings as a dividend. Vasta Platform pays out -- of its earnings as a dividend.

Afya quarterly revenues are $159.7M, which are larger than Vasta Platform quarterly revenues of $73.4M. Afya's net income of $43M is higher than Vasta Platform's net income of -$557.3K. Notably, Afya's price-to-earnings ratio is 11.53x while Vasta Platform's PE ratio is 4.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.31x versus 1.15x for Vasta Platform. Usually stocks with elevated PS ratios are considered overvalued.